share_log

Alibaba Health Information Technology (OTC:ALBHF) Stock Price Down 2.2%

Defense World ·  Dec 28, 2022 14:31

Alibaba Health Information Technology Limited (OTC:ALBHF – Get Rating) dropped 2.2% on Tuesday . The stock traded as low as $0.90 and last traded at $0.90. Approximately 5,010 shares changed hands during trading, a decline of 96% from the average daily volume of 115,639 shares. The stock had previously closed at $0.92.

Alibaba Health Information Technology Stock Performance

The company has a 50-day moving average of $0.73 and a two-hundred day moving average of $0.63.

Alibaba Health Information Technology Company Profile

(Get Rating)

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall.com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, sexual health and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform.

Featured Stories

  • Get a free copy of the StockNews.com research report on Alibaba Health Information Technology (ALBHF)
  • 3 Industrial Stocks to Help Build Your 2023 Watchlist
  • The Institutions Choose CarMax Over Carvana, Should You?
  • Heatmap in Trading: How to Learn What Market Depth Hides
  • Micron Technology Sees Chip Recovery by the End of 2023
  • Three Healthcare Penny Stocks to Watch In The New Year

Receive News & Ratings for Alibaba Health Information Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alibaba Health Information Technology and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment